(**) Products covered by valid patents are being developed under experimental aims in base of Art. 10(6) of Directive 2004/27/EC, exclusively directed to obtain market authorizations of our customers’ generic medicines.
Samples for R&D use in the United States are available as permitted under 35 USC § 271 (e) (1).
Products covered by valid patents in any country are not offered or supplied to these countries when such offer constitutes a patent infringement.
